Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Thiol/Disulfide Homeostasis and Ischemia Modified Albumin Levels in the Differential Diagnosis of Central and Peripheral Vertigo

NCT04070664 is registered in ClinicalTrials.gov with Ankara City Hospital Bilkent as lead sponsor.

NCT NCT04070664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04070664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Thiol/Disulfide Homeostasis and Ischemia Modified Albumin Levels in the Differential Diagnosis of Central and Peripheral Vertigo
Lead sponsor
Ankara City Hospital Bilkent
Phase
Observational
Overall status
Completed
Start date
July 1, 2018
Completion date
December 31, 2018
Enrollment
55 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diagnosis, oxidative stress, vertigo, central origin, vertigo, peripheral